Contamination controls in generic drug manufacturing prevent harmful adulteration from chemicals, microbes, or cross-contamination. Learn how cleanrooms, real-time monitoring, and human factors impact safety-and why failing to act risks recalls and regulatory shutdowns.
Continue ReadingBatch variability in pharmaceutical manufacturing can skew bioequivalence results, leading to incorrect approvals or rejections of generic drugs. Learn how regulators are updating standards to account for real-world manufacturing differences.
Continue ReadingHospital formularies carefully select generic drugs based on clinical safety, cost, and supply reliability-not just price. Learn how P&T committees evaluate generics, navigate rebates, and manage shortages to ensure patient care isn't compromised.
Continue Reading